Theranos is reportedly stopping its signature blood-testing method

Laboratory startup Theranos has reportedly stopped using finger pricks to collect blood samples for all except one of its tests, under pressure from federal regulators, The Wall Street Journal reports.

That follows months of scrutiny $US10 billion Theranos and its CEO, Elizabeth Holmes, have faced regarding its signature blood-testing method, which was thought to potentially revolutionise that industry.

You can read all about the Theranos controversy via Tech Insider

NOW WATCH: Kesha sued her producer for sexual assault, and she says it’s destroying her career

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.